Please login to the form below

Not currently logged in

Excellence in Healthcare Collaboration and Partnerships

Sponsored by

Back to results


OneHeart collaboration

by Atlantis Healthcare for AstraZeneca

Summary of work

AstraZeneca and the Bristol Heart Institute’s Joint Working project, OneHeart, aims to improve self-management and adherence to prescribed therapies among Acute Coronary Syndromes (ACS) patients. 15 per cent of patients die within one year of their first ACS event1 and 46 per cent of patients prescribed oral antiplatelets (OAP) stop using them within 12 months, more than doubling their likelihood of death or a non-fatal heart attack.2

In launching a new OAP treatment, AstraZeneca looked to truly partner with the NHS by viewing medicines as an opportunity to deliver a pioneering, outcomes-focused solution. Utilising health psychology research, this personalised, multimedia programme targets complex, unhelpful beliefs shown to be predictors of non-adherence.

OneHeart’s success demonstrates a pharma/NHS collaboration driving improved health outcomes in line with NHS objectives such as medicines optimisation – and is generating roll-out to a further 20 acute trusts.



1. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007;153:29-35.

2. Boggon R, van Staa TP, Timmis A, Hemingway H, Ray KK, Begg A, Emmas C, Fox KAA. (2011). Clopidogrel Discontinuation After Acute Coronary Syndromes: Frequency, Predictors and Associations with Death and Myocardial Infarctions  

Judges comments

A clear, well explained programme that is highly relevant, ambitious and creative for the long-term benefit of patients. We saw good evidence of genuine partnership, robust insights, process and validation and good tangible results to date. What was very clear was that they really thought about how to make this a proper partnership with everyone having joint roles. A fantastic entry that promises more results to come in the longer term.


Meningitis: Keep Watching - by Ruder Finn for Novartis Vaccines and Diagnostics Limited

Highly commended

Proving that it's good to talk about contraceptive health - by MHP Health Mandate for Bayer & the Advisory Group on Contraception

Highly commended

More than the sum of its parts - by MHP Health Mandate for Cancer Campaigning Group


OneHeart collaboration - by Atlantis Healthcare for AstraZeneca

The Psoriasis White Paper and Psoriasis Mandate - by Publicis Life Brands Resolute for Janssen & EUROPSO

Winners in Pictures

Photo Gallery

Back to results

Key dates

Entry deadline 10th March 2023
Extended entry deadline 17th March 2023
(additional fee applies)
Judging days 4th, 5th and 19th
May 2023
Awards Ceremony 6th July 2023

Contact information:

For sponsorship opportunities:
Sales Team
Tel: +44 (0)1372 414200

General event enquiries:
Debbie Tuesley
Tel: +44 (0)1372 414243

Entry and dinner booking enquiries:
Charlotte Garnade
Tel: 01372 414253